Literature DB >> 30172948

β2-Adrenergic receptor signaling mediates the preferential mobilization of differentiated subsets of CD8+ T-cells, NK-cells and non-classical monocytes in response to acute exercise in humans.

Rachel M Graff1, Hawley E Kunz1, Nadia H Agha1, Forrest L Baker2, Mitzi Laughlin1, Austin B Bigley2, Melissa M Markofski1, Emily C LaVoy1, Emmanuel Katsanis3, Richard A Bond4, Catherine M Bollard5, Richard J Simpson6.   

Abstract

Acute exercise preferentially mobilizes cytotoxic T-cells, NK-cells and non-classical monocytes to the bloodstream under the influence of hemodynamic forces and/or β2-adrenergic receptor (β2-AR) signaling. However, the relative contribution of these mechanisms to the redeployment of the most exercise-responsive cell types is largely unknown. We determined the lymphocyte and monocyte subtypes mobilized to blood during exercise via β2-AR signaling whilst controlling for β1-AR mediated reductions in hemodynamic forces. In a randomized, double blind, complete cross-over design, 14 healthy cyclists exercised for 30-minutes at +10% of blood lactate threshold after ingesting: (1) a placebo, (2) a β1-preferential antagonist (10 mg bisoprolol), or (2) a non-preferential β1 + β2-antagonist (80 mg nadolol) across three trials separated by >7-days. Bisoprolol was administered to reduce hemodynamic forces (heart rate and blood pressure) during exercise to levels comparable with nadolol but without blocking β2-ARs. The mobilization of total NK-cells, terminally differentiated (CD57+) NK-cells, central memory, effector memory and CD45RA+ effector memory CD8+ T-cells; non-classical monocytes; and γδ T-cells were significantly blunted or abrogated under nadolol compared to both bisoprolol and placebo, indicating that the exercise-induced mobilization of these cell types to the blood is largely influenced by β2-AR signaling. Nadolol failed to inhibit the mobilization of classical monocytes, CD4+ T-cells (and their subsets) or naïve CD8+ T-cells, indicating that these cell types are mobilized with exercise independently of the β2-AR. We conclude that the preferential mobilization of NK-cells, non-classical monocytes and differentiated subsets of CD8+ T-cells with exercise is largely dependent on catecholamine signaling through the β2-AR. These findings provide mechanistic insights by which distinct lymphocyte and monocyte subtypes are preferentially mobilized to protect the host from anticipated injury or infection in response to an acute stress response.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Beta-blockers, nadolol, bisoprolol, catecholamines; Exercise immunology; Hemodynamics; Neutrophils, cortisol; Receptor sensitivity; Shear stress; Trafficking

Mesh:

Substances:

Year:  2018        PMID: 30172948     DOI: 10.1016/j.bbi.2018.08.017

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  29 in total

1.  Circulating angiogenic cell response to sprint interval and continuous exercise.

Authors:  Louis O'Carroll; Bruce Wardrop; Ronan P Murphy; Mark D Ross; Michael Harrison
Journal:  Eur J Appl Physiol       Date:  2019-01-23       Impact factor: 3.078

2.  The effects of normoxic endurance exercise on erythropoietin (EPO) production and the impact of selective β1 and non-selective β1 + β2 adrenergic receptor blockade.

Authors:  Rod J Azadan; Nadia H Agha; Hawley E Kunz; Forrest L Baker; Preteesh L Mylabathula; Tracy A Ledoux; Daniel P O'Connor; Charles R Pedlar; Richard J Simpson
Journal:  Eur J Appl Physiol       Date:  2021-03-01       Impact factor: 3.078

Review 3.  Can physical activity ameliorate immunosenescence and thereby reduce age-related multi-morbidity?

Authors:  Niharika A Duggal; Grace Niemiro; Stephen D R Harridge; Richard J Simpson; Janet M Lord
Journal:  Nat Rev Immunol       Date:  2019-09       Impact factor: 53.106

Review 4.  Reframing How Physical Activity Reduces The Incidence of Clinically-Diagnosed Cancers: Appraising Exercise-Induced Immuno-Modulation As An Integral Mechanism.

Authors:  Annabelle Emery; Sally Moore; James E Turner; John P Campbell
Journal:  Front Oncol       Date:  2022-03-14       Impact factor: 6.244

5.  Exercise Training Improves Tumor Control by Increasing CD8+ T-cell Infiltration via CXCR3 Signaling and Sensitizes Breast Cancer to Immune Checkpoint Blockade.

Authors:  Igor L Gomes-Santos; Zohreh Amoozgar; Ashwin S Kumar; William W Ho; Kangsan Roh; Nilesh P Talele; Hannah Curtis; Kosuke Kawaguchi; Rakesh K Jain; Dai Fukumura
Journal:  Cancer Immunol Res       Date:  2021-04-10       Impact factor: 11.151

6.  Salutary effects of moderate but not high intensity aerobic exercise training on the frequency of peripheral T-cells associated with immunosenescence in older women at high risk of breast cancer: a randomized controlled trial.

Authors:  Grace M Niemiro; Adriana M Coletta; Nadia H Agha; Preteesh Leo Mylabathula; Forrest L Baker; Abenaa M Brewster; Therese B Bevers; Enrique Fuentes-Mattei; Karen Basen-Engquist; Emmanuel Katsanis; Susan C Gilchrist; Richard J Simpson
Journal:  Immun Ageing       Date:  2022-03-23       Impact factor: 6.400

Review 7.  Stress and cancer: mechanisms, significance and future directions.

Authors:  Anabel Eckerling; Itay Ricon-Becker; Liat Sorski; Elad Sandbank; Shamgar Ben-Eliyahu
Journal:  Nat Rev Cancer       Date:  2021-09-10       Impact factor: 60.716

Review 8.  Exercise mimetics: harnessing the therapeutic effects of physical activity.

Authors:  Carolina Gubert; Anthony J Hannan
Journal:  Nat Rev Drug Discov       Date:  2021-06-08       Impact factor: 84.694

Review 9.  The Effects of Lifestyle and Diet on Gut Microbiota Composition, Inflammation and Muscle Performance in Our Aging Society.

Authors:  Barbara Strasser; Maike Wolters; Christopher Weyh; Karsten Krüger; Andrea Ticinesi
Journal:  Nutrients       Date:  2021-06-15       Impact factor: 5.717

Review 10.  Neuroimmunology of cancer and associated symptomology.

Authors:  Nicole N Scheff; Jami L Saloman
Journal:  Immunol Cell Biol       Date:  2021-09-12       Impact factor: 5.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.